Roy Levitt
28Patents
8h-index
18Co-inventors
72Inventor score
Filing activity: Dec 8, 1992 → Jul 2, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5908839A | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders | Human Necessities | 83 | Expired |
| US6261559A | Methods of treating asthma with interleukin-9 antibodies | Human Necessities | 25 | Expired |
| US7192578B2 | Interleukin-9 mutein peptides | Human Necessities | 16 | Expired |
| US7700088B2 | Interleukin-9 mutein peptides | Human Necessities | 16 | Active |
| US7345051B2 | Mucin synthesis inhibitors | Chemistry; Metallurgy | 13 | Expired |
| US8637469B2 | Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US8940683B2 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors | Chemistry; Metallurgy | 11 | Active |
| US7504409B2 | Mucin synthesis inhibitors | Human Necessities | 8 | Expired |
| US6737427B2 | Mucin synthesis inhibitors | Human Necessities | 7 | Expired |
| US7981876B2 | Polymorphic and amorphous salt forms of squalamine dilactate | Chemistry; Metallurgy | 7 | Active |
| US6645492B2 | Methods of treating asthma with interleukin-9 receptor antibodies | Human Necessities | 6 | Expired |
| US6037149A | DNA encoding human asthma associated factor 1 | Human Necessities | 5 | Expired |
| US5384462A | Process and apparatus for localizing a source of charged particles using an electric field | Physics | 5 | Expired |
| US7074778B2 | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders | Physics | 3 | Expired |
| US6576434B1 | Methods for identification of agents which modulate chloride channel activity | Emerging Cross-Sectional Technologies | 3 | Expired |
| US10550389B2 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors | Chemistry; Metallurgy | 2 | Active |
| US7056698B2 | Nucleic acids encoding interleukin-9 receptor variants | Chemistry; Metallurgy | 1 | Expired |
| US6716603B2 | Nucleic acids encoding a chloride channel protein | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11091763B2 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7211254B2 | Methods for treating ICACC protein associated diseases | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7919248B2 | Methods for the modulation of IL-13 | Human Necessities | 0 | Active |
| US7208292B2 | Nucleic acid encoding an interleukin-9 receptor variant | Chemistry; Metallurgy | 0 | Expired |
| US11718853B2 | Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7384767B2 | Nucleic acid encoding an interleukin-9 receptor variant | Chemistry; Metallurgy | 0 | Active |
| US7704710B2 | Interleukin-9 receptor mutants | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.